Anti-neuroinflammatory terpenes from Magnolia grandiflora

Area of Science:

• Natural Product Chemistry
• Organic Chemistry
• Pharmacology

Background:

• Magnolia grandiflora L. is a source of diverse bioactive compounds.
• Sesquiterpenes are a significant class of natural products with various biological activities.
• Understanding the chemical diversity and bioactivity of M. grandiflora isolates is crucial.

Purpose of the Study:

• To isolate and characterize novel sesquiterpenes from Magnolia grandiflora leaves.
• To synthesize and identify new sesquiterpene derivatives.
• To evaluate the anti-neuroinflammatory potential of the isolated compounds.

Main Methods:

• Isolation of compounds using chromatographic techniques.
• Structure elucidation via extensive spectroscopic data (NMR, MS) and quantum chemical calculations.
• Chemical synthesis of sesquiterpene derivatives.
• In vitro anti-neuroinflammatory assays using BV-2 cells.

Main Results:

• Six new sesquiterpenes, magnogranoides A-F (1-6), and ten known terpenes were isolated.
• Novel tricyclic ring systems were identified in compounds 1 (8/5/5) and 2 (5/7/5).
• Four compounds (3, 7, 8, 16) demonstrated significant anti-neuroinflammatory activity (IC50 values 3.23–15.98 μM), outperforming minocycline.

Conclusions:

• The study successfully identified novel sesquiterpenes from M. grandiflora with unique structural features.
• Compounds 1 and 2 represent new structural classes of sesquiterpenes.
• Several isolated compounds possess potent anti-neuroinflammatory properties, suggesting therapeutic potential.
• The findings contribute to the chemotaxonomic understanding of Magnolia species.